Author, year
(total patients)
study type
|
MI/MS
(N)
|
Age
(y/o)
|
Age
(y/o)
|
Sex
(female) (no, %)
|
Sex
(female) (no, %)
|
Sex
(female) (no, %)
|
Sex
(female) (no, %)
|
BSA(m2)
BMI (kg/m2)
|
BSA(m2)
BMI (kg/m2)
|
Tumor Size
(max diameter cm)
|
Tumor Size
(max diameter cm)
|
Tumor Histology and Location
|
Tumor Histology and Location
|
|
|
MI |
MS |
MI |
MI |
MI |
MS |
MI |
MS |
MI |
MS |
MI |
MS |
Ravikumar, 2000
(n=5)
Retrospective
|
2/3
|
33.5
|
43.3
|
2 (100)
|
2 (100)
|
2 (100)
|
2 (66.3)
|
NA
|
NA
|
NA
|
NA
|
Myxoma 2 (100%)
|
Myxoma 2 (66.3%)
Chondrosarcoma 1 (33.3%)
|
Iribarne, 2010
(n=74)
Retrospective
|
38/36
|
52.4±2.8
|
59.9±2.6
|
29 (76.3)
|
29 (76.3)
|
29 (76.3)
|
23 (63.8)
|
26.5±1
|
26.7±0.8
|
8.5±1.7
|
13.2±2.6
|
Left atrium 16 (44.4%)
Right atrium 12 (33.3%)
Aorta 4 (11.1%)
Other 4 (11.1%)
Myxoma 18 (50%)
Papillary fibro. 8 (22.2%)
Thrombus 3 (8.3%)
Vascular malformation 4 (11.1%)
Other 3 (8.3%)
|
Left atrium 30 (79%)
Right atrium 4 (10.5%)
Aorta 3 (7.9%)
Other 1 (2.6%)
Myxoma 26 (68.4%)
Papillary fibro. 5 (13.2%)
Thrombus 4 (2.6%)
Vascular malformation 1 (2.6%)
Other 2 (5.3%)
|
Pineda, 2014
(n=39)
Retrospective
|
22/17
|
62±17
|
57±12
|
18 (81.8)
|
18 (81.8)
|
18 (81.8)
|
12 (70.6)
|
NA
|
NA
|
7.5 (4-19.7)
|
7.5 (4-19.7)
|
Left atrium 22 (56.4%)
Aortic valve 8 (20.5%)
Right atrium 6 (15.4%)
Left ventricle 2 (5.1%)
Right ventricle 1 (2.6%)
Myxoma 26 (66.7%)
Papillary fibro. 9 (23.1%)
Thrombus 4 (10.2%)
|
Left atrium 22 (56.4%)
Aortic valve 8 (20.5%)
Right atrium 6 (15.4%)
Left ventricle 2 (5.1%)
Right ventricle 1 (2.6%)
Myxoma 26 (66.7%)
Papillary fibro. 9 (23.1%)
Thrombus 4 (10.2%)
|
Shilling, 2012
(n=45)
Retrospective
|
16/29
|
53.1±15.2
|
58.8±11.4
|
58.8±11.4
|
11 (69)
|
21 (72)
|
21 (72)
|
34.6±6.8
|
28.6±5.3
|
NA
|
NA
|
Left atrium 16 (100%)
Myxoma 16 (100%)
|
Left atrium 29 (100%)
Myxoma 29 (100%)
|
Yang, 2015
(n=93)
Retrospective
|
49/44
|
47.7±13
|
51.2±12.1
|
51.2±12.1
|
25 (51)
|
26 (59)
|
26 (59)
|
23.2±3.6
|
23.5±3.8
|
4.8
|
4.3
|
Left atrium 45 (91.8%)
Right atrium 4 (8.1%)
Myxoma 49 (100%)
|
Left atrium 39 (88.6%)
Right atrium 5 (11.3%)
Myxoma 44 (100%)
|
Sawaki, 2015
(n=23)
Retrospective
|
7/16
|
68.7±7.8
|
62.6±18.1
|
62.6±18.1
|
3 (43.3)
|
12 (75%)
|
12 (75%)
|
23.4±2.4
|
23.9±4.1
|
16±9
|
16.7±8.9
|
Left atrium 6 (86%)
Right atrium 1 (14%)
Myxoma 7 (100%)
|
Left atrium 13 (81%)
Right atrium 2 (13%)
Other 1 (6%)
Myxoma 12 (75%)
Thrombus 2 (13%)
Hemangioma 1 (6%)
Hamartoma 1 (6%)
|
Lee, 2016
(n=146)
Retrospective
|
63/83
|
51.5±14.6
|
54.8±13.9
|
54.8±13.9
|
54 (86)
|
51 (61)
|
51 (61)
|
23±2.9
|
23.1±2.7
|
3.7±1.8
|
3.5±1.5
|
Left atrium 60 (95%)
Right atrium 3 (5%)
Myxoma 63 (100%)
|
Left atrium 75 (90%)
Right atrium 5 (6%)
Left ventricle 2 (3%)
Right ventricle 1 (1%)
Myxoma 83 (100%)
|
Moss, 2016
(n=69)
Retrospective
|
30/39
|
55.1±13.1
|
59.5±13.4
|
59.5±13.4
|
23 (76.7)
|
27 (69.2)
|
27 (69.2)
|
29±7.5
|
28.6±6.1
|
NA
|
NA
|
Left atrium 30 (100%)
|
Left atrium 39 (100%)
|
Dong, 2018
(n=66)
Retrospective
|
30/36
|
56±6.5
|
53.9±5.9
|
53.9±5.9
|
24 (80)
|
27 (75)
|
27 (75)
|
21.7±1.8
|
22.6±2.1
|
44.5±2.7
|
45.9±3.6
|
Left atrium 30 (100%)
Myxoma 30 (100%)
|
Left atrium 36 (100%)
Myxoma 36 (100%)
|
Ellouze, 2018
(n=43)
Retrospective
|
20/23
|
61±12
|
56±12
|
56±12
|
14 (70)
|
14 (61)
|
14 (61)
|
26±4
|
25±6
|
3.8±1.8
|
4.1±1.9
|
Left atrium 18 (90%)
Right atrium 2 (10%)
|
Left atrium 19 (82%)
Right atrium 4 (17.3%)
|
Lou, 2019
(n=50)
Retrospective
|
17/33
|
55.9±18.2
|
54.4±17.3
|
54.4±17.3
|
12 (70.6)
|
19 (57.6)
|
19 (57.6)
|
NA
|
NA
|
NA
|
NA
|
Left atrium 40 (80%)
Right atrium 8 (16%)
Left ventricle 1 (2%)
Right ventricle 1 (2%)
Myxoma 46 (92%)
Lipoma 2 (4%)
Rhabdomyoma 1 (2%)
Fibroma 1 (2%)
|
Left atrium 40 (80%)
Right atrium 8 (16%)
Left ventricle 1 (2%)
Right ventricle 1 (2%)
Myxoma 46 (92%)
Lipoma 2 (4%)
Rhabdomyoma 1 (2%)
Fibroma 1 (2%)
|
Data are presented as mean±SD or number.
BMI=body mass index. BSA= body surface area. MI=Minimally invasive.
MS=Median sternotomy.
|
Data are presented as mean±SD or number.
BMI=body mass index. BSA= body surface area. MI=Minimally invasive.
MS=Median sternotomy.
|
Data are presented as mean±SD or number.
BMI=body mass index. BSA= body surface area. MI=Minimally invasive.
MS=Median sternotomy.
|
Data are presented as mean±SD or number.
BMI=body mass index. BSA= body surface area. MI=Minimally invasive.
MS=Median sternotomy.
|
Data are presented as mean±SD or number.
BMI=body mass index. BSA= body surface area. MI=Minimally invasive.
MS=Median sternotomy.
|
Data are presented as mean±SD or number.
BMI=body mass index. BSA= body surface area. MI=Minimally invasive.
MS=Median sternotomy.
|
Data are presented as mean±SD or number.
BMI=body mass index. BSA= body surface area. MI=Minimally invasive.
MS=Median sternotomy.
|
Data are presented as mean±SD or number.
BMI=body mass index. BSA= body surface area. MI=Minimally invasive.
MS=Median sternotomy.
|
Data are presented as mean±SD or number.
BMI=body mass index. BSA= body surface area. MI=Minimally invasive.
MS=Median sternotomy.
|
Data are presented as mean±SD or number.
BMI=body mass index. BSA= body surface area. MI=Minimally invasive.
MS=Median sternotomy.
|
Data are presented as mean±SD or number.
BMI=body mass index. BSA= body surface area. MI=Minimally invasive.
MS=Median sternotomy.
|
Data are presented as mean±SD or number.
BMI=body mass index. BSA= body surface area. MI=Minimally invasive.
MS=Median sternotomy.
|
Data are presented as mean±SD or number.
BMI=body mass index. BSA= body surface area. MI=Minimally invasive.
MS=Median sternotomy.
|
Data are presented as mean±SD or number.
BMI=body mass index. BSA= body surface area. MI=Minimally invasive.
MS=Median sternotomy.
|